Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VI
NCT05932732Phase 4Completed
- Sponsor
- Austin Institute for Clinical Research
- Start
- Nov 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms), sponsored by Austin Institute for Clinical Research. Primary endpoints: Change in facial skin elasticity, wrinkles, roughness, fine lines, pigmentation, erythema, and pore size at Day 85, Change in facial aesthetic appearance at Day 85 and 3 more. Started Nov 2023; status: completed.
Beyond the preview
Go deeper on NCT05932732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05932732.